Clinical trials
Phase 2/3 Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre | 3 |
| S. Andrea Hospital | 3 |
| Oregon Health and Science University | 2 |
| VA Office of Research and Development | 2 |
| Biocad | 1 |
| Biogen | 1 |
| Brown, Theodore R., M.D., MPH | 1 |
| Charite University, Berlin, Germany | 1 |
| Clene Nanomedicine | 1 |
| Colorado State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 35 |
| Multiple Sclerosis, Chronic Progressive | 4 |
| Optic Neuritis | 3 |
| Cognitive Dysfunction | 2 |
| Demyelinating Diseases | 2 |
| Fatigue | 2 |
| Recurrence | 2 |
| Urinary Bladder, Neurogenic | 2 |
| Brain Injuries, Traumatic | 1 |
| Cerebral Palsy | 1 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.